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ABSTRACT 
Objective: The present investigation was aimed at developing and validating two novel highly sensitive, selective, accurate and simple 
spectrophotometric methods for the determination of Cinitapride tartrate (CNP) in bulk and its dosage forms  
Methods: Method A was based on molecular salt formation reaction of Cinitapride tartrate with Picric Acid to form a yellow coloured chromogen 
having absorption maxima of 410 nm*. Method B was based on the formation of an internal salt between Cinitapride tartrate and citric acid –acetic 
anhydrate system that was measured at 565 nm*. The factors affecting the reaction in both the methods were carefully studied and optimized. The 
kinetics of the reaction was investigated, and the reaction mechanism was postulated. 
Results: Under the optimized conditions, linear relationship with good correlation coefficient of was found between the absorbance and Cinitapride 
tartrate concentration in the range of 8-40 μg / mL and 4-20μg / mL for method A and B respectively. The precision of the method was satisfactory; 
the values of relative standard deviations did not exceed 1.4%. The proposed method was successfully applied to the determination of Cinitapride 
tartrate in its bulk form and pharmaceutical formulations with good accuracy. 
Conclusion: The proposed method was successfully applied to the determination of Cinitapride tartrate in its bulk form and pharmaceutical 
formulations with good accuracy. Hence, these methods can be used for the routine quality control of CNP in its dosage forms. 
Keywords: Cinitapride tartrate, Spectrophotometry, Picric Acid, Citric acid – Acetic anhydrate reagent. 
 
Cinitapride tartrate[1, 2] (CNP) is a gastrointestinal agent belonging 
to the classification of benzimidazole derivatives. Chemically it is 4-
amino-N-[3-(Cyclohexan-1-yl-methyl)-4-piperidinyl]-2-ethoxy-5-
nitrobenzamide. It is a gastro enteric prokineticagent acting via 
complex, but synergistic effects on serotonergic5-HT2 (inhibition) 
and 5-HT4 (stimulation) receptor and dopaminergicD2 (inhibition) 
receptors in the neuronal synapses of the myentericplexus.  
Literature survey reveals that a few UV-Visible 
spectrophotometric[3-8], HPTLC[9], RP-HPLC[10-12] methods have 
been reported for the estimation of CNP either in isolation or in 
combination of other drugs like pantaprazole[7,11] and omeprazole 
[8, 12]. However the analytically important functional groups of the 
drug have not been fully exploited for the sensitive and precise 
determination of drug. Hence, the aim of the present work was 
application of molecular salt formation reactions of picric acid and 
citric acid –acetic anhydrate system with cinitapride tartrate to 
develop simple, rapid, economic and accurate method for the 
estimation of the drug in bulk and pharmaceutical formulations and 
to validate it as per ICH Guidelines [13]. 
Instruments 
A Systronics Double beam UV visible spectrophotometer 2201 with 
1 cm matched quartz cells were used for all spectral and absorbance 
measurements. A Systronics digital pH meter was used for all pH 
measurements. 
Preparation of reagents 
All the chemicals and reagents used were of analytical grade and 
solutions were prepared in double distilled water. The procedures 
for preparation of the various reagents were mentioned below.  
Method A 
PA solution (PA) (Fluka: 0.4% w/v, 1.75 x 10-2 M): Prepared by 
dissolving 400 mg of picric acid in 100 mL of chloroform. 
Method B 
Citric acid–Acetic anhydrate system (CA/Ac2O) (Fluka: 0.2%w/v, 
3.26 x 10-3 M): Accurately 12 gm of citric acid monohydrate was 
weighed and transferred to 250 mL beaker. The beaker was kept in 
ice water bath. To this beaker 5 mL of methanol and 20 mL of acetic 
anhydride were added. The mixture was stirred with a glass rod to 
complete the solution. The solution was transferred to 100 mL 
volumetric flask and final volume adjusted to mark with acetic 
anhydride. 
Preparation cinitapride tartrate standard solution 
About 128.83 mg of CNP (equivalent to 100 mg of free base) was 
accurately weighed and transferred to 150 mL separating funnel. It 
was dissolved in 10 mL of water and 10 mL of 0.1 N sodium 
hydroxide was added to it drop wise to release the free base of the 
drug. The released free base was extracted 3 times with 20 mL 
portions of chloroform solvent and volume of the total chloroform 
extract was brought up to 100 mL with chloroform to get a standard 
stock solution of 1 mg/mL. The stock solution was further diluted to 
get the working standard solution of concentration 100 µg/mL. 
Preparation of sample solution 
Twenty tablets were weighed accurately and powdered. A quantity 
equivalent to 50 mg of cinitapride was weighed accurately and 
transferred to 100 mL volumetric flask. About 30 mL of chloroform 
was added and kept in an ultrasonic bath for 10 min. This solution is 
filtered through membrane filter and volume was made up to the 
mark with chloroform to get mg/mL concentration. The prepared 
solution was diluted quantitatively with chloroform to obtain a 
suitable concentration for the analysis. 
Recommended procedures 
Based on the results obtained in different trials described under 
results and discussion the following procedures were recommended 
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for the determination of CNP in bulk and pharmaceutical dosage 
formulations. 
Method A: To a series of 10 mL volumetric flasks, aliquots of 
standard chloroformic CNP solutions containing 80 to 400 µg were 
transferred and 1.0 mL of PA was added to each volumetric flask. 
The final volume was made up to the mark with chloroform solution. 
The absorbance of the solutions was measured at 410 nm against 
the corresponding reagent blank. The amount of CNP was calculated 
from the corresponding Beer-Lambert’s plot. 
Method B: Aliquots of standard chloroformic CNP solutions 
containing (0.4 -2.0 mL of 100 µg/mL) were transferred to a series 
of 25 mL volumetric flasks and gently evaporated on a water bath to 
remove the ch1oroform.10 mL of CA/Ac2O reagent was added to 
each volumetric flask. The volumetric flasks were placed in a water 
bath and heated for 40 min. The contents were cooled to room 
temperature and the solution in each volumetric flask was made up 
to the mark with acetic anhydride. The absorbance of coloured 
solutions was measured at 565 nm after 15 min against a reagent 
blank. The amount of CNP in sample was calculated from its 
calibration graph.  
The probable reaction based on analogy is presented below:  
Method A: Picric acid is a powerful proton acceptor because of 
presence of three electron withdrawing nitro groups, more formally 
called 2,4,6-trinitrophenol (TNP). These nitro aromatics are known 
to form a number of coloured addition products with a number of 
donors, especially with hydrocarbons, phenols and amines. Free 
picric acid exhibits no color in chloroformic solution but its complex 





Method B: Aconitic acid is normally prepared by dehydration of 
citric acid with sulphuric acid or acetic anhydride. When basic 
tertiary amines are heated with a solution of citric acid (or cis-
aconitic anhydride) in acetic anhydride, a red-violet coloured 
molecular internal salt was formed. The colour reactions were 
reported to be selective for tertiary amines. The trans-configuration 
of aconitic acid initially forms through dehydration besides cis- 
aconitic anhydride and subsequently yields α, γ-anhydride develops 
violet colour in the presence of tertiary amine which allows the 
colorimetric determination of the class of compounds. The color 
formation by Citric acid- acetic anhydride with tertiary amines may 
be explained as internal salt formation. The probable sequence of 




In order to ascertain the optimum wavelength of maximum 
absorption (λ max), the spectra were scanned in the wavelength 
region of 400 – 800 nm against a corresponding reagent blank. The 
reagent blank absorption spectrum of each method was recorded 
against solvent employed in each method.  
The beer’s plots of these systems were recorded. Beer’s law limits, 
molar absorptivity, sandell’s sensitivity and optimum photometry 
range for CNP in each method developed with mentioned reagents 
were calculated. Least square regression analysis was carried out for 
getting the slop, intercept and correlation coefficient values. These 
were recorded in Table 1. 
 
Table 1: Optical characteristics and regression analysis parameters, precision and accuracy of the proposed methods for CNP 
 Parameter MA MB 
λmax (nm) 410 565 
Beer’s law limits (μg/mL) 8-40 4-20 
Molar absorptivity (L. mole-1 cm1) 7.3x 103 1.6 x 105 
Detection limit (µg/mL) 1.1544 0.5436 
Sandell’s sensitivity 





Optimum photometric range (µg/mL) 10-50 5-30 






Standard deviation of slope (Sb) 2.5 x 10-4 4.0 x 10-4 
Intercept (a) 0.0043 0.0037 
Standard deviation of intercept (Sa) 0.0062 0.0049 
Standard error of estimation (Se) 0.0086 0.0067 
Correlation coefficient (r) 0.9991 0.9992 
% Relative standard deviation* 0.1389 0.1647 






0.01 level 0.2287 0.2711 
% Error in bulk samples** 0.1199 0.1011 
* Average of six determinations, ** Average of three determinations. 
 
Interference studies were conducted to see the influence of 
excipients with proposed methods. The accuracy of the methods was 
evaluated by estimating the amount of CNP in previously analyzed 
samples to which known amounts of CNP were spiked. The results of 
accuracy were given in Table 2. Some of the commercially available 
formulations were procured from the local market and analyzed by 
the developed methods and the results comply with the labelled 
claim (Table 2).  
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Proposed Method % recovery by proposed methods**±S. D 
Amount found* (mg) ±S. D t (value) F (Value) 
 MA 5 4.98 ± 0.012 0.576 1.458 99.71 ±0.79 
 10 10.02 ± 0.013 0.551 1.601 100.1± 0.85 
MB 5 5.01+0.122 0.153 2.474 100.9+0.61 
 10 9.91+0.057 0.075 1.104 100.61+1.01 
* Average ± standard deviation of six determinations, the t and F- values refer to comparison of the proposed method with the reference method. 
Theoretical values at 95 % confidence limit t = 2.571 and F = 5.05. ** Average of five determinations 
 
Finally it can be concluded that the proposed methods are economic, 
simple, sensitive, reproducible and accurate. Hence these can be 
used for the routine analysis of CNP in bulk as well as in its 
pharmaceutical preparations. 
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